成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Pomalidomide-PEG4-CO2H

Pomalidomide-PEG4-CO2H Struktur
2138440-81-8
CAS-Nr.
2138440-81-8
Englisch Name:
Pomalidomide-PEG4-CO2H
Synonyma:
Pomalidomide-PEG4-COOH;Poma-PEG4-COOH;Pomalidomide-PEG4-CO2H;POMALIDOMIDE-PEG4-CO 2 H;Pomalidomide 4'-PEG4-acid;Thalidomide-NH-PEG4-C2-COOH;1-[[2-(2,6-Dioxo-3-piperidyl)-1,3-dioxo-4-isoindolinyl]amino]-3,6,9,12-tetraoxapentadecan-15-oic Acid;1-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12-tetraoxapentadecan-15-oic acid;1-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino}-3,6,9,12-tetraoxapentadecan-15-oic acid;Propanoic acid, 3-[2-[2-[2-[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethoxy]-
CBNumber:
CB54846410
Summenformel:
C24H31N3O10
Molgewicht:
521.52
MOL-Datei:
2138440-81-8.mol

Pomalidomide-PEG4-CO2H Eigenschaften

Siedepunkt:
773.6±60.0 °C(Predicted)
Dichte
1.385±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
pka
4.28±0.10(Predicted)
Aggregatzustand
Viscous Liquid
Farbe
Light yellow to yellow

Sicherheit

Pomalidomide-PEG4-CO2H Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Protein degrader builiding block Pomalidomide-PEG4-CO2H enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology.This conjugate contains a Cereblon (CRBN)-recruiting ligand and a PEGylated crosslinker with pendant carboxylic acid for reactivity with an amine on the target ligand. Because even slight alterations in ligands and crosslinkers can affect ternary complex formation between the target, E3 ligase, and PROTAC, many analogs are prepared to screen for optimal target degradation. When used with other protein degrader building blocks with a pendant carboxyl group, parallel synthesis can be used to more quickly generate PROTAC libraries that feature variation in crosslinker length, composition and E3 ligase ligand.

Pomalidomide-PEG4-CO2H Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Pomalidomide-PEG4-CO2H Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 26)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
LEAPCHEM CO., LTD.
+86-852-30606658
market18@leapchem.com China 43340 58
Xian confluore Biological Technology Co., Ltd.
+86-15680926068 +86-15680926068
1924344760@confluore.cn China 2995 58
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 57505 58
ChemShuttle, Inc. 0510-83588313-802 18800520310;
sales@chemshuttle.com China 2996 62
Sigma-Aldrich 021-61415566 800-8193336
orderCN@merckgroup.com China 51456 80
Aikon International Limited 025-58851090 13611564524
lwan@aikonchem.com China 15951 58
SHANGHAI FDC-CHEMICAL CO.,LTD 021-61469567 13482353728
sales@fdc-chemical.com China 16285 58
Xi'an Confluore Biological Technology Co., Ltd. +86-156-80926068 +86-15680926068
1924344760@qq.com China 4824 58
Jilin Province Woda Biotechnology Co., Ltd. 13504435624
1927928688@qq.com China 1386 58
DC Chemicals 021-58447131 13564518121
sales@dcchemicals.com China 9410 58

  • POMALIDOMIDE-PEG4-CO 2 H
  • Pomalidomide-PEG4-CO2H
  • 1-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12-tetraoxapentadecan-15-oic acid
  • Pomalidomide-PEG4-COOH
  • Thalidomide-NH-PEG4-C2-COOH
  • Propanoic acid, 3-[2-[2-[2-[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]ethoxy]ethoxy]ethoxy]ethoxy]-
  • 1-[[2-(2,6-Dioxo-3-piperidyl)-1,3-dioxo-4-isoindolinyl]amino]-3,6,9,12-tetraoxapentadecan-15-oic Acid
  • 1-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-3,6,9,12-tetraoxapentadecan-15-oic acid, Crosslinker–E3 Ligase ligand conjugate, Protein degrader building block for PROTAC? research, Template for synthesis of targeted protein degrader
  • Poma-PEG4-COOH
  • Pomalidomide 4'-PEG4-acid
  • 1-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino}-3,6,9,12-tetraoxapentadecan-15-oic acid
  • 2138440-81-8
  • peg
Copyright 2019 ? ChemicalBook. All rights reserved